Here are the critical medicines in short supply in the EU, according to the latest available information from the EMA and ...

The technology is ready to start phase 3 testing in GSK’s asthma product Ventolin (salbutamol) next year, and according to the drugmaker has the potential to reduce greenhouse gas emissions from ...

GlaxoSmithKline Pharmaceuticals Limited is ... cephalexin was commenced at Ankleshwar and the salbutamol inhalers at Nashik. Glaxo rated amongst the first five of Indias most respected companies ...

Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown ... Chiesi, GlaxoSmithKline, MSD, Menarini, Novartis and Nycomed.

During Walmsley’s near eight-year tenure, GSK shares have delivered a total annualized return of about 3%, compared with more than 7% for peers, according to data compiled by Bloomberg. GSK has ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a prescription drug on LinkedIn. A panel of leaders at the PMCPA, pharma’s ...

Elizabeth Warren (D-Mass.) is asking a federal watchdog to investigate GSK for replacing a popular asthma inhaler with a so-called authorized generic at a much higher price in order to avoid ...

GSK’s Rockville location, which opened in Dec. 2016, was GSK’s first U.S. center dedicated to vaccine research and development, and hosts 350 employees, according to the company’s website.

Canada has announced a deal to secure 500K doses of GSK’s (NYSE:GSK) avian influenza vaccine for humans as the country steps up efforts to protect at-risk individuals and bolster its federal ...